Biography
I completed my undergraduate degree in Natural Sciences from Durham University in 2019. Following this, I completed an MPhil in the Biochemistry department at the University of Cambridge. My research project aimed to elucidate the mechanism by which a family of bacteriophages infects Dickeya solani, a phytopathogen, to ultimately determine whether they may be exploited as therapeutic agents.
I worked as a Research Associate for Isogenica, a biotechnology company with expertise in single domain therapeutics, where I worked towards developing VHH antibodies (nanobodies) as biotherapeutics for treating cancers and other disorders. I then worked as a Research Technician at Imperial College London where I characterised antibodies against the bacteria, Klebsiella pneumoniae.
Research
My PhD project, which is a collaboration between the veterinary medicine department and AstraZeneca, is looking at the use of VHH antibodies for the prevention and control of Campylobacter jejuni and Campylobacter coli.
